Search alternatives:
adoptive » adaptive (Expand Search)
Showing 1 - 20 results of 611 for search 'adoptive (cell OR well) transfer', query time: 0.15s Refine Results
  1. 1

    Adoptive transfer of natural killer cells in therapeutic treatment of COVID-19 patients by Abdulaziz Alamri

    Published 2025-02-01
    “…We discuss potential sources of NK cells for adoptive transfer therapy, critical factors influencing their therapeutic efficacy, and considerations for clinical translation in COVID-19 treatment. …”
    Get full text
    Article
  2. 2

    Clinically relevant orthotopic pancreatic cancer models for adoptive T cell transfer therapy by Gregory B. Lesinski, Chrystal M. Paulos, Maggie Phillips, Jacklyn Hammons, Isaac Karpovsky, Zaid Mahdi, Natalie K. Horvat, Megan M. Wyatt, Margaret A. Hall, Cameron J. Herting, Richard A. Moffitt

    Published 2024-01-01
    “…Immunotherapy, including adoptive T cell transfer therapy, has not impacted the outcomes in patients with PDAC, due in part to the hostile tumor microenvironment (TME) which limits T cell trafficking and persistence. …”
    Get full text
    Article
  3. 3
  4. 4
  5. 5

    Experimental myocardial infarction induces altered regulatory T cell hemostasis, and adoptive transfer attenuates subsequent remodeling. by Rinat Sharir, Jonathan Semo, Sara Shimoni, Tamar Ben-Mordechai, Natalie Landa-Rouben, Sofia Maysel-Auslender, Aviv Shaish, Michal Entin-Meer, Gad Keren, Jacob George, Jacob George

    Published 2014-01-01
    “…<h4>Background</h4>Ischemic cardiac damage is associated with upregulation of cardiac pro-inflammatory cytokines, as well as invasion of lymphocytes into the heart. Regulatory T cells (Tregs) are known to exert a suppressive effect on several immune cell types. …”
    Get full text
    Article
  6. 6
  7. 7

    Adoptively transferred macrophages for cancer immunotherapy by Jennifer L Guerriero, Kyung Soo Park, Alexander P Gottlieb, Morgan E Janes, Supriya Prakash, Neha Kapate, Vineeth Chandran Suja, Lily Li-Wen Wang, Samir Mitragotri

    Published 2025-05-01
    “…Here, we demonstrate that adoptively transferred macrophages, with optimal activation prior to administration, act as a potent cellular cancer therapeutic platform against a murine melanoma model.Method The macrophage therapy was prepared from bone marrow-derived macrophages, pretreated ex vivo with an activation cocktail containing interferon-γ, tumor necrosis factor-α, polyinosinic:polycytidylic acid, and anti-CD40 antibody. …”
    Get full text
    Article
  8. 8
  9. 9

    Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells by Gregory B Lesinski, Chrystal M Paulos, Hannah M Knochelmann, Megan M Wyatt, Guillermo O Rangel Rivera, Anna C Cole, Megen C Wittling

    Published 2024-06-01
    “…Background How distinct methods of host preconditioning impact the efficacy of adoptively transferred antitumor T helper cells is unknown.Methods CD4+ T cells with a transgenic T-cell receptor that recognize tyrosinase-related peptide (TRP)-1 melanoma antigen were polarized to the T helper 17 (Th17) phenotype and then transferred into melanoma-bearing mice preconditioned with either total body irradiation or chemotherapy.Results We found that preconditioning mice with a non-myeloablative dose of total body irradiation (TBI of 5 Gy) was more effective than using an equivalently dosed non-myeloablative chemotherapy (cyclophosphamide (CTX) of 200 mg/kg) at augmenting therapeutic activity of antitumor TRP-1 Th17 cells. …”
    Get full text
    Article
  10. 10

    ADOPTIVE CELL THERAPY: CURRENT ADVANCES by T. V. Shamova, A. O. Sitkovskaya, L. N. Vashchenko, E. E. Kechedzhieva

    Published 2020-03-01
    “…The main part of the article provides information on the mechanisms of adoptive T cell (unmodified and genetically modified) transfer, the creation of dendritic cell vaccines and cytokine-induced killers (CIK). …”
    Get full text
    Article
  11. 11

    Regional and intratumoral adoptive T-cell therapy by I. Olivera, I. Etxeberria, C. Luri-Rey, P. Molero-Glez, I. Melero

    Published 2024-12-01
    “…Building upon the experience of regional administration in other immunotherapies, the regional administration of adoptive cell therapies is being assessed to overcome this challenge, granting a first round of access of the transferred T cells to the tumor niche and thereby ensuring their activation and expansion. …”
    Get full text
    Article
  12. 12

    Adoptive transfer of membrane-restricted IL-12-TCR T cells promotes antigen spreading and elimination of antigen-negative tumor variants by James L Gulley, Ling Zhang, Christian S Hinrichs, John S Davies, Andrew Sinkoe, Wiem Lassoued, Farrah Karimipour, Philip Homan, Daniel Burnett, Scott M Norberg, Alex Kuznetsov, Margaret Cam, Ping Xue

    Published 2024-11-01
    “…Target antigen loss resulting either from non-uniform antigen expression or defects in antigen processing and presentation machinery is one well-characterized resistance mechanism. Constitutively expressed membrane-anchored interleukin-12 (caIL-12) has demonstrated enhanced antitumor activity and low systemic exposure in multiple preclinical adoptive T-cell treatment models with homogeneous tumor antigen expression. …”
    Get full text
    Article
  13. 13

    Platelet-derived microparticles adoptively transfer integrin β3 to promote antitumor effect of tumor-infiltrating T cells by Mimi Zhou, Yali Feng, Xiaoli Zhang, Jianguo Chen, Naijuan Yao, Shan Fu, Tianzhi Ni, Yi Chen, Fei Xie, Sahasrabda Roy, Jinfeng Liu, Yuan Yang, Yingli He, Yingren Zhao, Nan Yang

    Published 2024-12-01
    “…Furthermore, T cells and platelet-derived microparticles (PMPs) co-culture assay revealed that PMPs adoptively transferred integrin β3 to T cells and positively regulated T cell immune response. …”
    Get full text
    Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20